Patent · US Active

Anti-sclerostin antibody, antigen binding fragment and medical use thereof

US10449250B2 · kind B2 · utility

2Cited by

0References

20Claims

0Family size

Assignees

JIANGSU HENGRUI MEDICINE CO., LTD. · CN
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. · CN

Inventors

Jiajian Liu · Shanghai, CN
Yayuan FU · Shanghai, CN
Haoying ZHANG · Shanghai, CN
Yifang Wang · Dongguan, CN
Zhen Zhang · Shanghai, CN
Ling Zhang · Missouri City, US
Dongbing Cui · Shanghai, CN
Lianshan Zhang · 安丰镇, CN
Weikang Tao · Shanghai, CN

Key dates

Filing date	Feb 16, 2016
Grant date	Oct 22, 2019
Priority date	—
Expiry date	Feb 16, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a humanized antibody and chimeric antibody that specifically binds human sclerostin. The antibodies can be used for treating human bone metabolism related diseases such as osteoporosis (OP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.